Ulimorelin hydrochloride hydrate

CAS : 951326-02-6

Ref. 3D-BNB32602

Informations sur le produit

• Nom: Ulimorelin hydrochloride hydrate
• Marque: Biosynth
• Description: Ulimorelin hydrochloride hydrate is an inhibitor that has been shown to selectively induce apoptosis in cancer cells. This medicinal compound is a protein analog that inhibits the activity of kinases, which are enzymes that play a critical role in tumor growth and progression. Ulimorelin hydrochloride hydrate has been tested on human cancer cell lines and has demonstrated potent anticancer activity. Additionally, it has been found to have inhibitory effects on Chinese hamster ovary (CHO) cells, which suggests potential therapeutic applications beyond cancer treatment. Ulimorelin hydrochloride hydrate is excreted primarily via urine and may be the basis for future research in developing new kinase inhibitors for treating various types of cancer.

Propriétés chimiques

• Masse moléculaire: 593.1 g/mol
• Formule: C₃₀H₄₂ClFN₄O₅
• Degré de pureté: Min. 95%